NDC 51672-1312-01 - Mupirocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1312
- Requested NDC
- 51672-1312-01
- Package NDCs from labels
- 51672-1312-1, 51672-1312-0, 51672-1312-2, 51672-1312-01
- Manufacturer
- Sportpharm LLC
- Effective date
- 2026-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mupirocin - Sportpharm LLC | Sportpharm LLC | 2026-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - PAI Holdings, LLC dba PAI Pharma | PAI Holdings, LLC dba PAI Pharma | 2026-03-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - AvPAK | AvPAK | 2026-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Taro Pharmaceutical Industries Ltd. | 2025-07-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Lohxa | Lohxa LLC | Lohxa | Lohxa LLC | 2025-03-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - MAJOR PHARMACEUTICALS | MAJOR PHARMACEUTICALS | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2024-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Redpharm Drug | Redpharm Drug | 2024-06-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2023-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Proficient Rx LP | Proficient Rx LP | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | 2019-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Lake Erie Medical DBA Quality Care Products LLC | Lake Erie Medical DBA Quality Care Products LLC | 2019-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Mupirocin - Lohxa | Lohxa | 2018-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1312-0 | Mupirocin | 22 g in 1 TUBE | OINTMENT | 22 | 11 | |
| 51672-1312-0 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 11 | |
| 51672-1312-1 | Mupirocin | 15 g in 1 TUBE | OINTMENT | 15 | 11 | |
| 51672-1312-1 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 11 | |
| 51672-1312-2 | Mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 11 | |
| 51672-1312-2 | Mupirocin | 30 g in 1 TUBE | OINTMENT | 30 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1312 | MUPIROCIN OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 10 | Current NDC, Legacy NDC, 6 package rows | 20230203_900bb675-2f03-47e3-854e-257ec4831332.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1312-0 | GM - Gram | 51672-1312 | d6b135a5-57bb-4491-88b2-415997e9f345 | 1 | 2012-07-24 |
| 51672-1312-1 | GM - Gram | 51672-1312 | 66ed742f-057e-4a20-83ea-82bde7ad7e73 | 1 | 2017-05-03 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
| GaviLyte - C TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | Lupin Pharmaceuticals,Inc. | a8b15625-ca7c-4d57-9f36-3ac2a6d13665 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | G2M7P15E5P |
| e5046e20-8ab7-471b-b511-dbfd32900be7 | f7eafae0-c9cb-e6d5-e053-6394a90a1859 | 2025-09-04 | Warnings, Adverse reactions | f7eafae0-c9cb-e6d5-e053-6394a90a1859 | ||
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | G2M7P15E5P |
| b5eb1e91-08de-4c10-bdc2-483d82e5c77e | cd1f69fd-54fe-45e3-b80e-ac1f445415d5 | 2025-08-18 | Warnings, Adverse reactions | cd1f69fd-54fe-45e3-b80e-ac1f445415d5 | ||
| clearlax | POLYETHYLENE GLYCOL 3350 | Meijer, Inc. | 8cca18a8-94f6-43f6-bdb7-2d44a6cdf151 | 2025-08-08 | Warnings | G2M7P15E5P |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | B697894SGQ |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | ATLANTIC BIOLOGICALS CORP. | c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | 2025-07-22 | Warnings | G2M7P15E5P |
| Mupirocin | MUPIROCIN | Sun Pharmaceutical Industries, Inc. | 900bb675-2f03-47e3-854e-257ec4831332 | 2025-07-07 | Warnings, Adverse reactions | ANDA065170 51672-1312-2 51672-1312-0 51672-1312-1 51672-1312 51672131201 106346 3961a44e-34c2-d648-e063-6394a90a974e 900bb675-2f03-47e3-854e-257ec4831332 D0GX863OA5 |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Morning Star OTC | dcd4164c-aa1e-4f07-ab2c-b439275629db | 2025-06-16 | Warnings | B697894SGQ |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Kesin Pharma Corporation | 3729a1d2-4c98-dfdf-e063-6394a90a5a87 | 2025-06-12 | Warnings | G2M7P15E5P |
| CLEARLAX | POLYETHYLENE GLYCOL 3350 | STRATEGIC SOURCING SERVICES LLC | 041157b8-476c-e7d2-e063-6394a90ac3a0 | 2025-06-11 | Warnings | G2M7P15E5P |
| mupirocin | MUPIROCIN | ATLANTIC BIOLOGICALS CORP. | da2f7d4e-82c6-4790-8eea-3a97e5b30734 | 2025-05-28 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN OINTMENT | Kesin Pharma Corporation | b8e115ce-c8ff-4d08-b865-71dc4d0e51a1 | 2025-05-28 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Camber Consumer Care Inc | b321a7f5-f80b-4a51-9fd9-2c21fc1cae9b | 2025-04-23 | Warnings | G2M7P15E5P |
| good neighbor pharmacy clearlax | POLYETHYLENE GLYCOL 3350 | Amerisource Bergen | e0b419b6-6ce0-4aaa-948f-dee5b2ec2082 | 2025-04-17 | Warnings | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.